Published June 2, 2020 | Version v1
Dataset Open

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

  • 1. Brigham and Women's Hospital, Boston, MA, USA
  • 2. Surgisphere Corporation, Chicago, IL, USA
  • 3. University Hospital Zurich, Zurich, Switzerland
  • 4. University of Utah, Salt Lake City, UT, USA

Contributors

Data curator:

  • 1. Deakin University

Description

Recent reports have identified errors and implausible results in the title paper, few of which have been corrected to date. To facilitate analysis, I provide a spreadsheet containing all data from tables in the corrected version (2020-05-29), from both the main text (html) and supporting information (PDF).


The data is uploaded to this publicly-funded repository with the permission of the copyright holder: "Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories ... with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source." Text and data mining are also permitted: "These articles are also available to download with rights for full text and data mining, re-use and analyses for as long as needed."

Files

Files (42.6 kB)

Name Size Download all
md5:a6eff2f1a05c021893ddaa96b576b1f2
42.6 kB Download

Additional details

Related works

Is supplement to
Journal article: 10.1016/S0140-6736(20)31180-6 (DOI)

References

  • Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet, http://doi.org/ggwzsb
  • James Watson, 182 signatories. (2020). An open letter to Mehra et al and The Lancet. Zenodo. http://doi.org/dw8t